Document is current
Any future updates will be listed below
-
Authors
Ellis, Daniel
Lederhofer, Julia https://orcid.org/0000-0001-9096-9701
Acton, Oliver J. https://orcid.org/0000-0003-3928-2300
Tsybovsky, Yaroslav https://orcid.org/0000-0002-2159-5248
Kephart, Sally https://orcid.org/0000-0002-2285-511X
Yap, Christina
Gillespie, Rebecca A. https://orcid.org/0000-0001-5741-3699
Creanga, Adrian https://orcid.org/0000-0002-3087-8397
Olshefsky, Audrey https://orcid.org/0000-0002-4028-5587
Stephens, Tyler
Pettie, Deleah
Murphy, Michael https://orcid.org/0000-0002-8438-2653
Sydeman, Claire
Ahlrichs, Maggie
Chan, Sidney
Borst, Andrew J.
Park, Young-Jun https://orcid.org/0000-0003-2901-6949
Lee, Kelly K. https://orcid.org/0000-0001-5577-9873
Graham, Barney S. https://orcid.org/0000-0001-8112-0853
Veesler, David https://orcid.org/0000-0002-6019-8675
King, Neil P. https://orcid.org/0000-0002-2978-4692
Kanekiyo, Masaru https://orcid.org/0000-0001-5767-1532
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (ZIA AI005003)
- License Information
-
More Information
Article History
Received: 8 April 2021
Accepted: 14 March 2022
First Online: 5 April 2022
Competing interests
: D.E., J.L., B.S.G., N.P.K., and M.K. are named as inventors on patent applications filed by the University of Washington based on the studies presented in this paper. D.E. is a current employee of Icosavax, Inc. N.P.K. is a co-founder, shareholder, paid consultant, and chair of the scientific advisory board of Icosavax, Inc. The King lab has received unrelated sponsored research agreements from Pfizer. D.V. is a consultant for and has received an unrelated sponsored research agreement from Vir Biotechnology, Inc. The remaining authors declare no competing interests.
